[go: up one dir, main page]

AU2003217229A1 - Methods of modulating angiogenesis - Google Patents

Methods of modulating angiogenesis

Info

Publication number
AU2003217229A1
AU2003217229A1 AU2003217229A AU2003217229A AU2003217229A1 AU 2003217229 A1 AU2003217229 A1 AU 2003217229A1 AU 2003217229 A AU2003217229 A AU 2003217229A AU 2003217229 A AU2003217229 A AU 2003217229A AU 2003217229 A1 AU2003217229 A1 AU 2003217229A1
Authority
AU
Australia
Prior art keywords
methods
modulating angiogenesis
angiogenesis
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003217229A
Inventor
Lloyd P. Aiello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joslin Diabetes Center Inc
Original Assignee
Joslin Diabetes Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joslin Diabetes Center Inc filed Critical Joslin Diabetes Center Inc
Publication of AU2003217229A1 publication Critical patent/AU2003217229A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/16Ophthalmology
    • G01N2800/164Retinal disorders, e.g. retinopathy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003217229A 2002-01-22 2003-01-22 Methods of modulating angiogenesis Abandoned AU2003217229A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35116902P 2002-01-22 2002-01-22
US60/351,169 2002-01-22
PCT/US2003/001749 WO2003061520A2 (en) 2002-01-22 2003-01-22 Methods of modulating angiogenesis

Publications (1)

Publication Number Publication Date
AU2003217229A1 true AU2003217229A1 (en) 2003-09-02

Family

ID=27613468

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003217229A Abandoned AU2003217229A1 (en) 2002-01-22 2003-01-22 Methods of modulating angiogenesis

Country Status (2)

Country Link
AU (1) AU2003217229A1 (en)
WO (1) WO2003061520A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1865071A1 (en) * 2006-06-09 2007-12-12 Rheinische Friedrich-Wilhelms-Universität Bonn Method for early diagnosis of proliferative diabetic retinopathy
US8372582B2 (en) * 2006-08-01 2013-02-12 Joslin Diabetes Center, Inc. Methods of modulating metabolic memory

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156551A (en) * 1998-06-05 2000-12-05 Beth Israel Deaconess Medical Center Activated mutants of SH2-domain-containing protein tyrosine phosphatases and methods of use thereof

Also Published As

Publication number Publication date
WO2003061520A3 (en) 2003-12-18
WO2003061520A2 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
AU2003202924A1 (en) Variation of neural-stimulation parameters
AU2003234613A1 (en) Method of modulating angiogenesis
AU2003286746A1 (en) Modulators of angiogenesis and tumorigenesis
AU2003251968A1 (en) A method for the modulation of angiogenesis
AU2003270066A1 (en) Modulators of angiogenesis
AU2003277596A1 (en) Method of deuterization
AU2002306918A1 (en) Methods of modulating angiogenesis
AU2003224712A1 (en) Modulating angiogenesis
AU2003255787A1 (en) Modulation of immune function
AUPS096002A0 (en) Method of construction
AU2001280588A1 (en) Methods of modulating angiogenesis
AU2003282437A1 (en) Crutch
AU2003269268A1 (en) Modulation of immune function
AU2003295790A1 (en) Modulation of iap-like expression
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
AU2003290763A1 (en) Modulation of jumonji expression
AU2003298671A1 (en) Modulation of notch3 expression
AU2003294465A1 (en) Modulation of notch2 expression
AU2002307413A1 (en) Modulators of angiogenesis
AU2003242827A1 (en) Packer
AU2003244347A1 (en) Angiogenesis inhibitors
AU2003217229A1 (en) Methods of modulating angiogenesis
AU2003295794A1 (en) Modulation of stat2 expression
AU2003234867A1 (en) Rollator
AU2003208685A1 (en) Podologic aid

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase